Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral Neuropathy

NCT02372578 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

115

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated due to futility analysis.

Conditions

Painful Diabetic Peripheral Neuropathy (PDPN)

Interventions

DRUG: ASP3662
DRUG: pregabalin
DRUG: ASP3662 placebo
DRUG: pregabalin placebo

Sponsor

Astellas Pharma Global Development, Inc.